Health Care

Health Care Recent News

Ocugen (OCGN) Stock Tumbles After $22.5 Million Share Offering
Ocugen (OCGN) Stock Tumbles After $22.5 Million Share Offering
Ocugen shares sank sharply Wednesday after the biotech company announces a $22.5 million underwritten offering of common stock.
Telix Pharmaceuticals Reports Strong Full-Year Revenue, But Shares Remain Under Pressure
Telix Pharmaceuticals Reports Strong Full-Year Revenue, But Shares Remain Under Pressure
Telix Pharmaceuticals meets its FY25 revenue target with strong Q4 growth, expanded U.S. launches and ongoing trials.
Boston Scientific Advises Removal Of Certain AXIOS Stents After Deployment Issues Surface
Boston Scientific Advises Removal Of Certain AXIOS Stents After Deployment Issues Surface
FDA is reviewing AXIOS stent delivery issues after Boston Scientific reported injuries and deaths, urging facilities to stop use and remove affected devices.
Qiagen Explores Possible Sale After New Buyer Talks: Report
Qiagen Explores Possible Sale After New Buyer Talks: Report
Qiagen is reviewing strategic options, including a potential sale, after renewed takeover interest from several buyers.
Big-Pharma Partner Harbour BioMed Boosts Stake In Spruce Biosciences
Big-Pharma Partner Harbour BioMed Boosts Stake In Spruce Biosciences
Harbour BioMed exercises its warrant to buy Spruce Biosciences shares, raising its stake to about 3.8% as the companies work together on the SPR202 drug program.
What Sparked Anteris Technologies (AVR) Stock Surge Over 52% After-Hours?
What Sparked Anteris Technologies (AVR) Stock Surge Over 52% After-Hours?
Anteris Technologies shares surged over 52% in after-hours trading following the announcement of a $200 million public offering and a strategic investment from Medtronic.
Moderna–Merck Cancer Vaccine Shows Durable Benefit At 5 Years In High-Risk Melanoma
Moderna–Merck Cancer Vaccine Shows Durable Benefit At 5 Years In High-Risk Melanoma
Moderna and Merck shared five-year study data showing their combined cancer treatment cut the risk of melanoma coming back or causing death by nearly half compared with Keytruda alone.
Valneva Steps Back From US Approval Bid For Chikungunya Vaccine
Valneva Steps Back From US Approval Bid For Chikungunya Vaccine
Valneva withdraws U.S. applications for its chikungunya vaccine Ixchiq after the FDA suspended the license and placed studies on hold following new reports of serious adverse events.
Corvus Stock Spikes On Heels Of Strong Eczema Study Results
Corvus Stock Spikes On Heels Of Strong Eczema Study Results
Corvus Pharma reports encouraging data for its eczema drug soquelitinib, showing strong skin improvement and no serious safety issues.
Bristol Myers, Microsoft Aim To Catch Lung Cancer Early With New AI Tool
Bristol Myers, Microsoft Aim To Catch Lung Cancer Early With New AI Tool
Bristol Myers Squibb partners with Microsoft to use AI imaging tools to detect lung cancer earlier and support radiologists.
Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved